Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Atopic Dermatitis”

147 trials

Showing 20 of 147 results

Early research (Phase 1)Study completedNCT02379507
What this trial is testing

DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study

Who this might be right for
Eczema
Medicus Research, LLC 20
Not applicableActive Not RecruitingNCT06052995
What this trial is testing

Observational Study to Evaluate Use of Elidel® in South and East Asian Pediatric Patients With Atopic Dermatitis.

Who this might be right for
Mild to Moderate Atopic Dermatitis
BGP Products Operations GmbH, a Viatris company 130
Large-scale testing (Phase 3)Study completedNCT06631170
What this trial is testing

Efficacy and Safety of Roflumilast Cream in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 354
Not applicableStudy completedNCT06687512
What this trial is testing

A Clinical Study to Assess the Safety and Effectiveness of Test Products in Mild to Moderate Atopic Dermatitis (AD) Patients.

Who this might be right for
Atopic Dermatitis
NovoBliss Research Pvt Ltd 44
Large-scale testing (Phase 3)Study completedNCT02896101
What this trial is testing

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Glenmark Pharmaceuticals Ltd. India 755
Testing effectiveness (Phase 2)Study completedNCT00076375
What this trial is testing

Preliminary Study of Safety and Efficacy of Nanocrystalline Silver Cream in Atopic Dermatitis (Eczema)

Who this might be right for
Atopic DermatitisEczema
Nucryst Pharmaceuticals 180
Testing effectiveness (Phase 2)Study completedNCT04753034
What this trial is testing

Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Teres Bio, Inc. 63
Not applicableWithdrawnNCT01691209
What this trial is testing

Efficacy/Safety Study to Explore a New Topical Formulation in Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Bayer
Testing effectiveness (Phase 2)Study completedNCT06309355
What this trial is testing

Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Hangzhou Yirui Pharmaceutical Technology Co., Ltd 35
Early research (Phase 1)Study completedNCT03250663
What this trial is testing

Eucrisa for Atopic Dermatitis

Who this might be right for
Mild to Moderate Atopic Dermatitis
Wake Forest University Health Sciences 28
Testing effectiveness (Phase 2)Study completedNCT03571620
What this trial is testing

Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Qurient Co., Ltd. 258
Testing effectiveness (Phase 2)Study completedNCT05375955
What this trial is testing

Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Who this might be right for
Atopic DermatitisPlaque Psoriasis
Pfizer 263
Large-scale testing (Phase 3)Study completedNCT05571943
What this trial is testing

Study to Assess the Long-term Safety of Difamilast Ointment 1% in Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Acrotech Biopharma Inc. 542
Testing effectiveness (Phase 2)Study completedNCT02068352
What this trial is testing

Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Otsuka Pharmaceutical Development & Commercialization, Inc. 121
Post-approval studies (Phase 4)Study completedNCT00121316
What this trial is testing

Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients

Who this might be right for
Atopic Dermatitis
Novartis 200
Not applicableStudy completedNCT01948869
What this trial is testing

Efficacy/Safety Study to Explore a New Revised Topical Formulation in Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Bayer 35
Testing effectiveness (Phase 2)Study completedNCT03235024
What this trial is testing

Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis Eczema
AOBiome LLC 122
Post-approval studies (Phase 4)Study completedNCT00509990
What this trial is testing

Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Study completedNCT01232985
What this trial is testing

Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults

Who this might be right for
Atopic DermatitisPruritus
Oculus Innovative Sciences, Inc. 17
Early research (Phase 1)Study completedNCT06009094
What this trial is testing

Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD 80
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation